AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Immusol, Inc. (10790 Roselle St., San Diego, CA, 92121; Tel: 858/824-1100, Fax: 858/823-1112; Website: www.immusol.com) and Chugai Biopharmaceuticals, Inc. (CBI), a wholly owned subsidiary of Chugai Pharmaceutical Co. Ltd., (Japan) have entered into a functional genomics collaboration for drug discovery. Immusol's gene inactivation technology (Inverse Genomics) will be used to support Chugai's discovery and validation of drug target genes relating to cancer metastasis to inhibit the spread of cancer. The collaboration will also target newly discovered genes from Chugai's wholly owned subsidiary, Chugai Research …